Cancer and inflammation: promise for biologic therapy.
Cancers often arise as the end stage of inflammation in adults, but not in children. As such there is a complex interplay between host immune cells during neoplastic development, with both an ability to promote cancer and limit or eliminate it, most often complicit with the host. In humans, defining inflammation and the presence of inflammatory cells within or surrounding the tumor is a critical aspect of modern pathology. Groups defining staging for neoplasms are strongly encouraged to assess and incorporate measures of the presence of apoptosis, autophagy, and necrosis and also the nature and quality of the immune infiltrate. Both environmental and genetic factors enhance the risk of cigarette smoking, Helicobacter pylori, hepatitis B/C, human papilloma virus, solar irradiation, asbestos, pancreatitis, or other causes of chronic inflammation. Identifying suitable genetic polymorphisms in cytokines, cytokine receptors, and Toll-like receptors among other immune response genes is also seen as high value as genomic sequencing becomes less expensive. Animal models that incorporate and assess not only the genetic anlagen but also the inflammatory cells and the presence of microbial pathogens and damage-associated molecular pattern molecules are necessary. Identifying micro-RNAs involved in regulating the response to damage or injury are seen as highly promising. Although no therapeutic strategies to prevent or treat cancers based on insights into inflammatory pathways are currently approved for the common epithelial malignancies, there remains substantial interest in agents targeting COX2 or PPARgamma, ethyl pyruvate and steroids, and several novel agents on the horizon.
Demaria
Sandra
S
Department of Pathology, New York University School of Medicine, New York, NY, USA.
Pikarsky
Eli
E
Karin
Michael
M
Coussens
Lisa M
LM
Chen
Yen-Ching
YC
El-Omar
Emad M
EM
Trinchieri
Giorgio
G
Dubinett
Steven M
SM
Mao
Jenny T
JT
Szabo
Eva
E
Krieg
Arthur
A
Weiner
George J
GJ
Fox
Bernard A
BA
Coukos
George
G
Wang
Ena
E
Abraham
Robert T
RT
Carbone
Michele
M
Lotze
Michael T
MT
D056704:Adaptive Immunity; D000328:Adult; D000818:Animals; D001691:Biological Therapy / Q000639:trends; D002648:Child; D004195:Disease Models, Animal; D006801:Humans; D007113:Immunity, Innate; D007249:Inflammation; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*
N Engl J Med. 2006 Aug 31;355(9):885-95
16943401
Immunol Rev. 2008 Apr;222:145-54
18363999
J Immunol. 2006 Jun 15;176(12):7154-8
16751357
Radiat Res. 2006 Dec;166(6):839-48
17149983
Nat Rev Cancer. 2007 Apr;7(4):256-69
17384581
N Engl J Med. 1993 May 6;328(18):1313-6
8385741
Infect Immun. 2003 Jun;71(6):3496-502
12761134
ANZ J Surg. 2008 Jun;78(6):432-6
18522560
Cancer Biomark. 2005;1(6):259-69
17192050
J Immunother. 2005 Jan-Feb;28(1):1-9
15614039
Cancer Lett. 2007 Sep 18;255(1):145-52
17574329
Cancer Cell. 2005 May;7(5):411-23
15894262
Prostate. 2006 Oct 1;66(14):1556-64
16921508
Cancer Cell. 2004 Nov;6(5):447-58
15542429
Immunol Rev. 2002 Oct;188:22-32
12445278
J Exp Med. 1999 Nov 15;190(10):1417-26
10562317
Nat Immunol. 2007 Jan;8(1):11-3
17179963
Methods Enzymol. 2009;452:181-97
19200883
J Immunol. 2009 Oct 15;183(8):5023-31
19794066
Nat Genet. 2007 May;39(5):638-44
17401364
J Clin Gastroenterol. 2001 Sep;33(3):177-9
11500602
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5243-8
17875751
Cancer. 1995 Mar 15;75(6 Suppl):1478-83
7889478
Science. 2006 Sep 29;313(5795):1960-4
17008531
N Engl J Med. 2009 Apr 16;360(16):1679; author reply 1679-80
19373967
Cancer Cell. 2008 Nov 4;14(5):408-19
18977329
Gastroenterology. 2001 Oct;121(4):823-9
11606496
Cell. 2008 Jan 11;132(1):27-42
18191218
Immunity. 2008 Jul 18;29(1):21-32
18631454
Genes Dev. 1999 Jun 1;13(11):1382-97
10364156
Arthritis Rheum. 2009 Apr;60(4):1065-75
19333922
J Urol. 2005 Jun;173(6):1969-74
15879794
Gastroenterology. 2007 Mar;132(3):905-12
17324405
Nat Genet. 2007 May;39(5):631-7
17401366
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2735-40
19193853
Cell. 2006 Feb 24;124(4):823-35
16497591
J Clin Oncol. 2005 Dec 10;23(35):8959-67
16219934
J Immunol. 2009 May 15;182(10):6562-8
19414811
Crit Rev Oncol Hematol. 2007 Feb;61(2):104-39
16945550
N Engl J Med. 2008 Feb 28;358(9):910-9
18199855
N Engl J Med. 2007 May 24;356(21):2131-42
17522398
Biochem Pharmacol. 2005 Nov 25;70(11):1579-92
16226725
Pathology. 1993 Oct;25(4):338-43
8164994
Nat Med. 2008 May;14(5):518-27
18438415
Int J Cancer. 2002 May 10;99(2):229-37
11979438
Gastroenterology. 2003 Aug;125(2):364-71
12891537
J Cell Physiol. 1999 Mar;178(3):275-83
9989773
Cancer Cell. 2006 Jul;10(1):51-64
16843265
Clin Cancer Res. 2007 May 15;13(10):2836-48
17504981
Cancer. 2000 Jun 15;88(12):2686-92
10870050
J Clin Oncol. 2007 Jun 20;25(18):2586-93
17577038
N Engl J Med. 2000 Jul 13;343(2):78-85
10891514
Cancer Prev Res (Phila). 2008 Jun;1(1):32-8
18841250
Immunity. 2009 Jan 16;30(1):80-91
19144316
Gut. 2001 Jun;48(6):743-7
11358884
Cancer Res. 2007 Mar 15;67(6):2649-56
17363585
Cancer Immunol Immunother. 2007 Sep;56(9):1459-69
17279413
Gastroenterology. 2008 Jan;134(1):306-23
18166359
J Urol. 1999 Jan;161(1):152-5
10037388
Biochem Biophys Res Commun. 2009 Mar 13;380(3):437-41
19284987
Cancer Res. 2004 Apr 15;64(8):2918-22
15087412
Nat Rev Immunol. 2005 Apr;5(4):331-42
15803152
N Engl J Med. 2006 Aug 31;355(9):873-84
16943400
Gastroenterology. 2006 Dec;131(6):1674-82
17087947
Nat Genet. 2007 May;39(5):645-9
17401363
Immunol Rev. 2008 Apr;222:155-61
18364000
J Clin Oncol. 2007 Jun 20;25(18):2506-8
17577026
Dev Comp Immunol. 2004 May 3;28(5):461-85
15062644
Trends Immunol. 2007 Oct;28(10):429-36
17845865
Clin Cancer Res. 2004 Mar 1;10(5):1565-73
15014005
N Engl J Med. 2003 Mar 6;348(10):883-90
12621132
J Immunol. 2003 Sep 15;171(6):3119-27
12960338
Biochim Biophys Acta. 2009 Jun;1792(6):497-505
19268705
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10397-10402
16798876
J Exp Med. 2007 May 14;204(5):1037-47
17438063
J Natl Cancer Inst. 2002 Nov 20;94(22):1680-7
12441323
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43
16344461
Adv Exp Med Biol. 2005;560:11-8
15932016
Cancer Res. 2006 Jan 15;66(2):605-12
16423985
Cancer Res. 2005 Dec 15;65(24):11771-8
16357190
J Leukoc Biol. 2009 Sep;86(3):599-607
19584311
J Immunol. 2006 Dec 15;177(12):8701-7
17142771
Clin Cancer Res. 2008 Apr 1;14(7):2095-101
18381950
J Immunother. 2007 Sep;30(6):596-606
17667523
Hepatology. 2009 Aug;50(2):565-74
19492424
Clin Cancer Res. 2004 Nov 15;10(22):7466-74
15569976
Mol Endocrinol. 1996 Sep;10(9):1077-83
8885242
Nature. 2008 Jul 24;454(7203):436-44
18650914
Cancer Res. 2006 Dec 1;66(23):11238-46
17114237
N Engl J Med. 1996 Apr 18;334(16):1018-22
8598839
J Leukoc Biol. 2007 Jan;81(1):119-28
17062605
Cancer Res. 2008 Aug 15;68(16):6482-5
18701469
Nature. 2000 Mar 23;404(6776):398-402
10746728
Clin Cancer Res. 2004 Oct 1;10(19):6502-11
15475437
Science. 1997 Nov 7;278(5340):1073-7
9353183
Nature. 2009 Nov 5;462(7269):99-103
19890330
Anticancer Res. 2003 Nov-Dec;23(6D):5015-22
14981961
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Cancer Res. 1998 Aug 15;58(16):3491-4
9721846
J Natl Cancer Inst. 2007 Apr 4;99(7):545-57
17405999
J Immunother. 2007 Jan;30(1):16-28
17198080
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Nat Rev Cancer. 2006 Jan;6(1):24-37
16397525
Clin Cancer Res. 2007 Dec 15;13(24):7271-9
18094407
J Clin Invest. 2006 Jul;116(7):1935-45
16778987
Cancer Res. 2008 Dec 15;68(24):10128-36
19074879
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):352-5
17301271
Cancer Immunol Immunother. 1994 Jan;38(1):31-7
8299116
J Leukoc Biol. 2007 Jan;81(1):75-83
16968820
BMC Cancer. 2005 Sep 21;5:121
16176582
J Immunol. 2005 Dec 1;175(11):7661-8
16301676
Nat Med. 2008 Nov;14(11):1271-7
18931683
Int Immunol. 2005 Jan;17(1):1-14
15585605
N Engl J Med. 2000 Jun 29;342(26):1946-52
10874062
J Clin Invest. 2006 Oct;116(10):2777-90
17016559
Nat Genet. 2000 Jun;25(2):187-91
10835634
RNA. 2009 Oct;15(10):1797-804
19690100
Yale J Biol Med. 2006 Dec;79(3-4):123-30
17940622
J Transl Med. 2009 Mar 17;7:17
19292913
J Leukoc Biol. 2009 Sep;86(3):625-32
19487305
Nat Clin Pract Oncol. 2008 Jun;5(6):348-56
18446144
Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;61(6):409-14
1349780
Expert Opin Pharmacother. 2003 Dec;4(12):2193-204
14640918
Gastroenterology. 2003 May;124(5):1193-201
12730860
Clin Cancer Res. 2007 Apr 15;13(8):2422-8
17438101
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5330-5
19289845
N Engl J Med. 2003 Mar 6;348(10):891-9
12621133
Gut. 1998 Feb;42(2):227-34
9536948
Nat Rev Immunol. 2004 Jun;4(6):469-78
15173835
Immunol Rev. 2007 Dec;220:60-81
17979840
J Cell Mol Med. 2009 Jan;13(1):24-38
19175698
Int J Cancer. 2005 Nov 20;117(4):574-86
15912532
J Leukoc Biol. 2007 Jan;81(1):1-5
17032697
J Natl Cancer Inst. 2005 Sep 21;97(18):1317-9
16174847
Lab Invest. 2005 Mar;85(3):388-96
15696191
J Exp Med. 2005 Apr 4;201(7):1135-43
15795240
Cell Death Differ. 2010 Apr;17(4):666-76
19834494
Curr Opin Investig Drugs. 2008 Dec;9(12):1259-63
19037832
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7595-9
9207137